These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38976067)

  • 21. Outcome of pulpotomy in permanent teeth with irreversible pulpitis: a systematic review and meta-analysis.
    Ather A; Patel B; Gelfond JAL; Ruparel NB
    Sci Rep; 2022 Nov; 12(1):19664. PubMed ID: 36385132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical influencing factors of vital pulp therapy on pulpitis permanent teeth with 2 calcium silicate-based materials: A randomized clinical trial.
    Zhang L; Yin L; Wu J; Wang X; Huang J; Li Q
    Medicine (Baltimore); 2024 May; 103(18):e38015. PubMed ID: 38701294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial pulpotomy with two bioactive cements in permanent teeth of 6- to 18-year-old patients with signs and symptoms indicative of irreversible pulpitis: a noninferiority randomized controlled trial.
    Uesrichai N; Nirunsittirat A; Chuveera P; Srisuwan T; Sastraruji T; Chompu-Inwai P
    Int Endod J; 2019 Jun; 52(6):749-759. PubMed ID: 30638262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mineral trioxide aggragate pulpotomy for the treatment of immature permanent teeth with irreversible pulpitis: a preliminary clinical study].
    Peng C; Zhao Y; Yang Y; Qin M
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Dec; 50(12):715-9. PubMed ID: 26887394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of mature permanent teeth with irreversible pulpitis by cervical pulpotomy: A systematic review.
    Skitioui M; Seck A; Niang SO; Fikhar A; Touré B
    Aust Endod J; 2023 Sep; 49 Suppl 1():488-493. PubMed ID: 36149016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of treatment outcome of partial pulpotomy using different agents in permanent teeth-a randomized controlled trial.
    Singh DVV; Taneja S; Fatima S
    Clin Oral Investig; 2023 Sep; 27(9):5171-5180. PubMed ID: 37460903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of vital pulp treatment in permanent teeth with carious pulp exposure with signs and symptoms of irreversible pulpitis.
    Sriudomdech P; Santiwong B; Linsuwanont P
    Clin Oral Investig; 2024 Sep; 28(10):551. PubMed ID: 39320508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of pulpotomy for permanent teeth with carious pulp exposure: A systematic review and meta-analysis of randomized controlled trials.
    Li W; Yang B; Shi J
    PLoS One; 2024; 19(7):e0305218. PubMed ID: 38968236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally invasive endodontics: a new era for pulpotomy in mature permanent teeth.
    Philip N; Suneja B
    Br Dent J; 2022 Dec; 233(12):1035-1041. PubMed ID: 36526777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of complete and partial pulpotomy in mature permanent teeth with symptomatic irreversible pulpitis: A randomized clinical trial.
    Ramani A; Sangwan P; Tewari S; Duhan J; Mittal S; Kumar V
    Int Endod J; 2022 May; 55(5):430-440. PubMed ID: 35226769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulpotomy for teeth with irreversible pulpitis in immature permanent teeth: a retrospective case series study.
    Zhang N; Kang Q; Cheng Y
    Sci Rep; 2024 Mar; 14(1):6395. PubMed ID: 38493190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Complete Pulpotomy With Biodentine on Mature Permanent Molars With Signs and Symptoms of Symptomatic Irreversible Pulpitis: 12-months Follow-up.
    Anta S; Diouma N; Ousmane NS; Fatou LB; Florence F; Babacar T
    J Endod; 2022 Mar; 48(3):312-319. PubMed ID: 34974080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of pulpotomy in managing irreversible pulpitis in mature permanent teeth: A systematic review and meta-analysis.
    Li Y; Wang W; Zeng Q; Tang M; Massey J; Bergeron BE; Gu L; Tay FR
    J Dent; 2024 May; 144():104923. PubMed ID: 38461884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of Mineral Trioxide Aggregate Pulpotomy for Mature Permanent Molars with Symptoms Indicative of Irreversible Pulpitis.
    Hussain MI; Bashar AM
    Mymensingh Med J; 2022 Jan; 31(1):223-229. PubMed ID: 34999706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective study of iRoot BP Plus pulpotomy compared with Vitapex pulpectomy for irreversible pulpitis of primary molars with the presence of coronal pulp tissue.
    Hu X; Liang Z; Wang Q; Liu L
    Int J Paediatr Dent; 2023 Mar; 33(2):216-226. PubMed ID: 36453980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-year results of vital pulp therapy in permanent molars with irreversible pulpitis: an ongoing multicenter, randomized, non-inferiority clinical trial.
    Asgary S; Eghbal MJ; Ghoddusi J; Yazdani S
    Clin Oral Investig; 2013 Mar; 17(2):431-9. PubMed ID: 22431145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcomes of pulpotomy in permanent teeth with irreversible pulpitis: A multi-center randomized controlled trial.
    Asgary S; Eghbal MJ; Bagheban AA
    Am J Dent; 2017 Jun; 30(3):151-155. PubMed ID: 29178761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth.
    Çelik BN; Mutluay MS; Arıkan V; Sarı Ş
    Clin Oral Investig; 2019 Feb; 23(2):661-666. PubMed ID: 29744721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulpotomy for carious pulp exposures in permanent teeth: A systematic review and meta-analysis.
    Li Y; Sui B; Dahl C; Bergeron B; Shipman P; Niu L; Chen J; Tay FR
    J Dent; 2019 May; 84():1-8. PubMed ID: 30981748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of Direct Pulp Capping by Using Either ProRoot Mineral Trioxide Aggregate or Biodentine in Permanent Teeth with Carious Pulp Exposure in 6- to 18-Year-Old Patients: A Randomized Controlled Trial.
    Parinyaprom N; Nirunsittirat A; Chuveera P; Na Lampang S; Srisuwan T; Sastraruji T; Bua-On P; Simprasert S; Khoipanich I; Sutharaphan T; Theppimarn S; Ue-Srichai N; Tangtrakooljaroen W; Chompu-Inwai P
    J Endod; 2018 Mar; 44(3):341-348. PubMed ID: 29275850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.